Copyright
©2013 Baishideng Publishing Group Co.
World J Neurol. Dec 28, 2013; 3(4): 97-114
Published online Dec 28, 2013. doi: 10.5316/wjn.v3.i4.97
Published online Dec 28, 2013. doi: 10.5316/wjn.v3.i4.97
Table 2 CHADS2, CHA2DS2VASC, and HAS-BLED risk stratification methods
CHADS2 | |
Congestive heart failure | 1 |
Hypertension | 1 |
Age ≥ 75 yr | 1 |
Diabetes mellitus | 1 |
Stroke, TIA, or thromboembolism | 2 |
Maximum score | 6 |
CHA2DS2VASc | |
Congestive heart failure/LV dysfunction | 1 |
Hypertension | 1 |
Age ≥ 75 yr | 2 |
Diabetes mellitus | 1 |
Stroke, TIA, or thromboembolism | 2 |
Vascular disease (previous MI, PAD, or aortic plaque) | 1 |
Age 65-74 yr | 1 |
Sex category (female sex) | 1 |
Maximum score | 9 |
HAS-BLED | |
Hypertension | 1 |
Abnormal renal/liver function | 1 point each |
Stroke | 1 |
Bleeding history or predisposition | 1 |
Labile INR | 1 |
Elderly (age > 65 yr) | 1 |
Drugs (e.g., concomitant antiplatelet/NSAID) or alcohol | 1 point each |
Maximum score | 9 |
- Citation: Volonghi I, Padovani A, Zotto ED, Giossi A, Costa P, Morotti A, Poli L, Pezzini A. Secondary prevention of ischaemic stroke. World J Neurol 2013; 3(4): 97-114
- URL: https://www.wjgnet.com/2218-6212/full/v3/i4/97.htm
- DOI: https://dx.doi.org/10.5316/wjn.v3.i4.97